Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5864 Articles

Douglas A. McIntyre | Apr 12, 2011 at 8:35 PM EDT

Buying A $100,000 Kidney: A Story of Supply and Demand

The idea of compensating donors of vital organs, which strikes many as morally repugnant, is gaining acceptance among some parts…

Jon C. Ogg | Apr 11, 2011 at 2:01 PM EDT

ETF Watch: Biotechs Fighting M&A Shrinkage (BBH, AMGN, GILD, BIIB, XBI, FBT, CRA, CEPH, IBB)

Biotech is becoming the ever-shrinking stock sector. It is almost weekly now that a new biotech acquisition is announced. Big Pharma in…

Jon C. Ogg | Apr 11, 2011 at 11:11 AM EDT

Dividend Watch: Making Income From Healthcare Facility REITs (OHI, MPW)

We have been featuring many REITs for their high dividends on our daily “Dividend Watch” pieces. One sector which has not…

Jon C. Ogg | Apr 6, 2011 at 10:08 AM EDT

BioWatch: Curis Gets Further on Cancer Map (CRIS)

Curis Inc. (NASDAQ: CRIS) is not exactly a household name, even when it comes to the land of biotech investors. …

Jon C. Ogg | Apr 5, 2011 at 11:30 AM EDT

BioWatch: Cubist Moves Beyond Patent Fears (CBST, TEVA)

Cubist Pharmaceuticals Inc. (NASDAQ: CBST) is going to be back in favor now that it has settled a key patent…

Jon C. Ogg | Apr 4, 2011 at 9:38 AM EDT

BioWatch: VIVUS & Orexigen Looking More FDA-Favorable (VVUS, OREX, ARNA)

VIVUS Inc. (NASDAQ: VVUS) was recently shown as one of our five biotechs with 50% upside and news this morning…

Jon C. Ogg | Apr 1, 2011 at 12:17 PM EDT

BioWatch: Dendreon Looks Even Brighter (DNDN)

Earlier this week, we highlighted Dendreon Corporation (NASDAQ: DNDN) as one of five biotechs with 50% implied upside. A new…

Jon C. Ogg | Mar 31, 2011 at 8:55 AM EDT

DrugWatch: K-V Tries a Do-Over Approach on Makena (KV-A)

When we first covered K-V Pharmaceutical Co. (NYSE: KV-A) for its Makena drug market exclusivity to prevent premature birth, we…

Jon C. Ogg | Mar 30, 2011 at 10:48 AM EDT

BioWatch: Biotechs With 50% Implied Upside (GENZ, CEPH, ALNY, DNDN, GERN, HALO, VVUS)

Biotech is about to become even less of a diversified sector due to mergers and acquisitions. Genzyme Corporation (NASDAQ: GENZ)…

Jon C. Ogg | Mar 29, 2011 at 1:01 PM EDT

IPO Watch: The Alternative Genzyme IPO (SNY, GENZ, GCVRZ, BBH, IBB, FBT)

The proposed buyout of Genzyme Corporation (NASDAQ: GENZ) by Sanofi-Aventis (NYSE: SNY) should close this week. We are about to…

Jon C. Ogg | Mar 29, 2011 at 9:25 AM EDT

BioWatch: CryoLife Acquisition, It Is Not Crying (CRY, CGCP)

CryoLife, Inc. (NYSE: CRY) is one we generally consider as devices rather than true biohealth, but it often falls under…

Jon C. Ogg | Mar 28, 2011 at 10:01 AM EDT

BioHealth Watch: Cancer Wars (BMY, DNDN, VICL)

The fight against melanoma just got a new weapon after a drug called Yervoy, or ipilimumab, was given FDA approval…

Jon C. Ogg | Mar 25, 2011 at 9:37 AM EDT

Biotech Daily: Prana Still Worth Speculative Look (PRAN)

Prana Biotechnology Ltd. (NASDAQ: PRAN) may have left shareholders feeling like they got the wool pulled over their eyes this…

Jon C. Ogg | Mar 24, 2011 at 12:27 PM EDT

M&A Daily: Is Drugstore.com Worth the Price? (WAG, CHSI, DSCM)

It was not that long ago that Walgreen Co. (NYSE: WAG) sold off its PBM unit to Catalyst Health Solutions,…

Jon C. Ogg | Mar 24, 2011 at 11:10 AM EDT

Daily Dividend: Will Amgen Finally Start Paying Shareholders? (AMGN, PFE, MRK)

It is time for “The Daily Dividend” and we have an interesting call ahead. How long has it been that…

1 … 327 328 329 330 331 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

Buying A $100,000 Kidney: A Story of Supply and Demand

ETF Watch: Biotechs Fighting M&A Shrinkage (BBH, AMGN, GILD, BIIB, XBI, FBT, CRA, CEPH, IBB)

Dividend Watch: Making Income From Healthcare Facility REITs (OHI, MPW)

BioWatch: Curis Gets Further on Cancer Map (CRIS)

BioWatch: Cubist Moves Beyond Patent Fears (CBST, TEVA)

BioWatch: VIVUS & Orexigen Looking More FDA-Favorable (VVUS, OREX, ARNA)

BioWatch: Dendreon Looks Even Brighter (DNDN)

DrugWatch: K-V Tries a Do-Over Approach on Makena (KV-A)

BioWatch: Biotechs With 50% Implied Upside (GENZ, CEPH, ALNY, DNDN, GERN, HALO, VVUS)

IPO Watch: The Alternative Genzyme IPO (SNY, GENZ, GCVRZ, BBH, IBB, FBT)

BioWatch: CryoLife Acquisition, It Is Not Crying (CRY, CGCP)

BioHealth Watch: Cancer Wars (BMY, DNDN, VICL)

Biotech Daily: Prana Still Worth Speculative Look (PRAN)

M&A Daily: Is Drugstore.com Worth the Price? (WAG, CHSI, DSCM)

Daily Dividend: Will Amgen Finally Start Paying Shareholders? (AMGN, PFE, MRK)

This Natural Resources ETF Has Silently Outperformed The S&P 500 Year-To-Date While Yielding 5%

XRP vs Solana vs Ethereum: Which Altcoin is the Best Buy for Upside Right Now?

Brinker CEO Kevin Hochman: “We Are Firing on All Cylinders” After 20 Straight Quarters of Growth

39% of Americans Are Betting on Crypto and Prediction Markets Instead of Saving

A $300,000 Annuity Guarantees $1,900 a Month for Life, but Here Is What Retirees Are Giving Up

This Natural Resources ETF Has Silently Outperformed The S&P 500 Year-To-Date While Yielding 5%

XRP vs Solana vs Ethereum: Which Altcoin is the Best Buy for Upside Right Now?

Health and Healthcare Articles

All Health and Healthcare Articles

Buying A $100,000 Kidney: A Story of Supply and Demand

ETF Watch: Biotechs Fighting M&A Shrinkage (BBH, AMGN, GILD, BIIB, XBI, FBT, CRA, CEPH, IBB)

Dividend Watch: Making Income From Healthcare Facility REITs (OHI, MPW)

BioWatch: Curis Gets Further on Cancer Map (CRIS)

BioWatch: Cubist Moves Beyond Patent Fears (CBST, TEVA)

BioWatch: VIVUS & Orexigen Looking More FDA-Favorable (VVUS, OREX, ARNA)

BioWatch: Dendreon Looks Even Brighter (DNDN)

DrugWatch: K-V Tries a Do-Over Approach on Makena (KV-A)

BioWatch: Biotechs With 50% Implied Upside (GENZ, CEPH, ALNY, DNDN, GERN, HALO, VVUS)

IPO Watch: The Alternative Genzyme IPO (SNY, GENZ, GCVRZ, BBH, IBB, FBT)

BioWatch: CryoLife Acquisition, It Is Not Crying (CRY, CGCP)

BioHealth Watch: Cancer Wars (BMY, DNDN, VICL)

Biotech Daily: Prana Still Worth Speculative Look (PRAN)

M&A Daily: Is Drugstore.com Worth the Price? (WAG, CHSI, DSCM)

Daily Dividend: Will Amgen Finally Start Paying Shareholders? (AMGN, PFE, MRK)

This Natural Resources ETF Has Silently Outperformed The S&P 500 Year-To-Date While Yielding 5%

XRP vs Solana vs Ethereum: Which Altcoin is the Best Buy for Upside Right Now?

Brinker CEO Kevin Hochman: “We Are Firing on All Cylinders” After 20 Straight Quarters of Growth

Featured Reads

39% of Americans Are Betting on Crypto and Prediction Markets Instead of Saving

A $300,000 Annuity Guarantees $1,900 a Month for Life, but Here Is What Retirees Are Giving Up